Kazia Therapeutics Ltd ADR Cash Flow Quality Index
Kazia Therapeutics Ltd ADR cash flow quality index. Kazia Therapeutics Ltd ADR (KZIA) has a Cash Flow Quality Index of -18.50x as of December 2017. Operating cash flow of $-7.86 Million is below net income of $424.78K, suggesting accrual-heavy earnings not yet converted to cash. See Kazia Therapeutics Ltd ADR leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Kazia Therapeutics Ltd ADR (2000–2012)
Cash flow quality index of Kazia Therapeutics Ltd ADR from 2000 to 2012. Historical Cash Flow Quality Index for Kazia Therapeutics Ltd ADR across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Kazia Therapeutics Ltd ADR service its debt to assess how comfortably operating cash covers total debt obligations.
Kazia Therapeutics Ltd ADR Cash Flow Quality Index by Year (2000–2012)
Kazia Therapeutics Ltd ADR cash flow quality index by year from 2000 to 2012. Year-by-year earnings quality comparison for Kazia Therapeutics Ltd ADR. For the full cash flow conversion analysis, see Kazia Therapeutics Ltd ADR operating cash flow efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2012 | -5.61x | $-7.35 Million | $1.31 Million | ▼ -550.5% |
| 2000 | -0.86x | $-18.75 Million | $21.73 Million | — |